Difference between revisions of "Bleeding Disorder"

From Anthony Nolan Medical Guidelines
Jump to navigation Jump to search
 
(8 intermediate revisions by 4 users not shown)
Line 2: Line 2:
 
QUALIFIED
 
QUALIFIED
  
==Acceptability at CT / Work-Up==
+
==Acceptability at VT / Work-Up==
 
QUALIFIED
 
QUALIFIED
  
Line 14: Line 14:
  
 
==Guidance==
 
==Guidance==
 +
 +
=== Guidance at recruitment ===
 +
 +
Acceptable
 +
 +
=== Guidance at VT ===
 
Discuss with medical officer.
 
Discuss with medical officer.
  
Line 31: Line 37:
 
Assess the donor for personal and family history of excessive bleeding and bruising.
 
Assess the donor for personal and family history of excessive bleeding and bruising.
  
• Has the donor noticed any excessive bleeding – e.g. after injuries or cuts?
+
*Do you have any bleeding symptoms such as frequent nose bleeds, bleeding from the back passage or bleeding from the gums?  
 
+
*Have you ever consulted a doctor or received treatment for prolonged or unusual bleeding e.g. with nosebleeds or minor wounds?  
• Has the donor noticed any excessive bleeding e.g. after injuries or cuts?
+
*Do you experience bruises/haematomas larger than 2cm without trauma, or severe bruising after minor trauma?  
 
+
*Have you ever had surgery (major or minor) or any dental procedures? If yes - Have you ever experienced or been told you had prolonged or excessive bleeding after or during these procedures or required medical attention for this?  
• Does the donor experience heavy periods?
+
*Is there anyone in your family who suffers from a bleeding disorder e.g. Haemophilia/Von Willebrand disease?  
 
+
If assigned female at birth:
• Any issues with bleeding that was difficult to stop following an operation or tooth extraction?
+
*Have you ever consulted a doctor or received treatment for heavy or prolonged menstrual periods (contraceptive pill, iron etc.)?
 
+
*Have you given birth - If yes - Did you experience prolonged or excessive bleeding after delivery?
• Does the donor experience nosebleeds? If so, how often do they happen, are the nosebleeds from one nostril or both, how long do they take to stop and what measures are needed for the nosebleeds to stop?
 
 
 
• Has the donor ever experienced significant joint swelling? (i.e. potentially bleeding into their joints).
 
 
 
• Has the donor noticed any easy bruising?
 
 
 
• Has the donor had any blood clots in the past?
 
 
 
• Are there any family members with bleeding disorders, or abnormal bleeding or bruising?
 
 
 
• Are there any family members who have had blood clots?
 
 
 
 
 
  
If the history is reassuring, repeat the coagulation screen as spurious results can occur.
+
If the history is reassuring, repeat the coagulation screen with relevant factor levels as spurious results can occur.
  
Abnormalities should be discussed on an individual basis.
+
If APTT remains prolonged in isolation but factor levels are normal and there is no bleeding history - the donor can be cleared if the CC are in agreement. If there are concerns from the CC or regarding bleeding history discuss case with a clotting specialist.
  
 
==Pseudonyms or Related Conditions==
 
==Pseudonyms or Related Conditions==
Line 74: Line 67:
 
Platelet Disorder
 
Platelet Disorder
 
==Version==
 
==Version==
Version 1, Edition 1
+
Version 1, Edition 2
  
 
====Date of Last Update====
 
====Date of Last Update====
15th June 2012
+
17th September 2025

Latest revision as of 13:27, 17 September 2025

Acceptability at Recruitment

QUALIFIED

Acceptability at VT / Work-Up

QUALIFIED

Individual at Risk

Donor

Explanation of Condition

Most haemophilias are inherited disorders of blood clotting. They may be of varying severity, but generally prohibit bone marrow donation.

Some haemophilias are acquired during life, and may be transient.

Guidance

Guidance at recruitment

Acceptable

Guidance at VT

Discuss with medical officer.

For known history:

Unacceptable if history of excessive spontaneous or provoked bleeding, or laboratory demonstrated severe or moderate haemophilia (including asymptomatic factor XI deficiency).

Female carriers of haemophilia A and B should be discussed with medical officer. Consider for PBSC only if bleeding risk thought to be negligeable and after liaison with haemophilia centre.

Not for central venous catheter insertion or bone marrow harvest.

Any degree of factor XII deficiency is acceptable as long as there is no history of thrombosis.


For newly identified clotting abnormalities at medical:

Assess the donor for personal and family history of excessive bleeding and bruising.

  • Do you have any bleeding symptoms such as frequent nose bleeds, bleeding from the back passage or bleeding from the gums?
  • Have you ever consulted a doctor or received treatment for prolonged or unusual bleeding e.g. with nosebleeds or minor wounds?
  • Do you experience bruises/haematomas larger than 2cm without trauma, or severe bruising after minor trauma?
  • Have you ever had surgery (major or minor) or any dental procedures? If yes - Have you ever experienced or been told you had prolonged or excessive bleeding after or during these procedures or required medical attention for this?
  • Is there anyone in your family who suffers from a bleeding disorder e.g. Haemophilia/Von Willebrand disease?

If assigned female at birth:

  • Have you ever consulted a doctor or received treatment for heavy or prolonged menstrual periods (contraceptive pill, iron etc.)?
  • Have you given birth - If yes - Did you experience prolonged or excessive bleeding after delivery?

If the history is reassuring, repeat the coagulation screen with relevant factor levels as spurious results can occur.

If APTT remains prolonged in isolation but factor levels are normal and there is no bleeding history - the donor can be cleared if the CC are in agreement. If there are concerns from the CC or regarding bleeding history discuss case with a clotting specialist.

Pseudonyms or Related Conditions

Haemophilia A

Haemophilia B

Factor XIII, XI, VIII, VII or V Deficiency

Hypofibrinogenaemia

Dysfibrinogenaemia

Von Willebrand Disease

Platelet Function Defect

Platelet Disorder

Version

Version 1, Edition 2

Date of Last Update

17th September 2025